首页 | 本学科首页   官方微博 | 高级检索  
     


Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction
Authors:Yu-Chien Lee MD  MPH  Joshua K. Lin MD  ScD  Darae Ko MD  MSc  Susan Cheng MD  MMSc   MPH  Elisabetta Patorno MD  DrPH  Robert J. Glynn PhD  ScD  Theodore Tsacogianis MPH  Dae Hyun Kim MD  ScD
Affiliation:1. Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA;2. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA;3. Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA

Section of Cardiovascular Medicine, Boston University School of Medicine, Boston, Massachusetts, USA;4. Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA;5. Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA

Abstract:
Keywords:angiotensin receptor neprilysin inhibitor  frailty  guideline-directed medical therapy  heart failure with reduced ejection fraction
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号